CMN Weekly (20 May 2022) - Your Weekly CRISPR Medicine News
Some of the best links we picked up around the internet
By: Gorm Palmgren - May. 20, 2022
Top picks
CRISPR gene editing is now possible in cockroaches (Blattella germanica). The Japanese and Spanish researchers used the straightforward and effective "direct parental" CRISPR (DIPA-CRISPR) procedure that involves injecting materials into female adults where eggs are developing rather than into the embryos themselves. The authors believe that the same approach can be used to gene edit more than 90% of insect species.
Researchers from Rice University, Texas, have achieved large-scale multiplex base- and prime-editing in human cells. The scientists developed a so-called drive-and-process (DAP) CRISPR array architecture that leverages an engineered 75-nt human cysteine tRNA to release individual gRNAs by the cellular endogenous tRNA processing machinery. Up to 31 and 3 loci, respectively, could be base-edited and prime-edited simultaneously, potentially treating polygenic diseases.
Researchers in China describe an advanced system for spatial-controlled RNA editing and precise cancer therapy. The system employs self-uncloaking CRISPR-Cas13a–customised RNA nanococoons (RNCOs-D), featuring tumour-specific recognition and spatial-controlled activation of Cas13a. NCOs-D consists of programmable RNA nanosponges (RNSs) capable of targeted delivery and nanocapsules (NCs) anchored on RNSs for cloaking Cas13a/crRNA ribonucleoprotein activity.
American researchers introduce a pathway model to direct correction of point mutations after CRISPR-Cas12a gene editing. The method utilises templates for homology-directed correction. When used in a cell-free gene-editing system, the authors could directly correct four unique point mutations, including two unique nucleotide mutations at two separate targeted sites.
Chinese researchers have developed a dual-response fluorescent probe that can act as a reporter with CRISPR-Cas12a-based biosensing platforms. The ssDNA probe is dually labelled with fluorescein (FAM) and tetramethylrhodamine (TAMRA). Upon cleavage by activated Cas12a, there will be a decrease in the TAMRA's fluorescence and an increase in the FAM's fluorescence. Compared with the classic TaqMan, the new system exhibited higher sensitivity and could distinguish and avoid false-positive signals.
A review by scientists from India seeks to decrypt the mechanistic basis of the CRISPR-Cas9 protein. The authors discuss how a better understanding of the structural and sequence-based understanding of the whole CRISPR-associated bacterial ortholog family landscape and the underlying energetics of the CRISPR-Cas9 system can reveal critical parameters to design better CRISPR-Cas9s.
Regulation and opinion
An article in the CRISPR Journal discusses the concept of vulnerability and the ethics concerning human germline genome editing. The authors from Singapore and Australia highlight the role that vulnerability - e.g., situations in which research participants and other individuals may be at a heightened risk of experiencing harm - can play in ethical debates about human heritable genome editing.
News from CRISPR Medicine News
Monday's feature was about the successful use of CRISPR-Cas9 to selectively disrupt a mutant PSEN1 allele that causes familial Alzheimer’s disease. We interviewed Evangelos Konstantinidis, the first author of the proof-of-concept study, showing that gene editing in human fibroblasts may reverse Alzheimer's disease phenotypes by reducing the accumulation of extracellular amyloid-β deposits.
On Wednesday, the clinical update reported on a new base-editing cholesterol-reducing therapy that has been approved for a clinical trial in New Zealand. The treatment, VERVE-101, is developed by Verve Therapeutics.
Our sister-site CRISPR AgroBio News (CARBON) launched its bi-weekly newsletter on Tuesday with links to recent news from CRISPR in agriculture. The top story was the introduction of a single base mutation in SOC1 in lettuce that delayed bolting, i.e., when crops put on a vertical growth spurt to flower and set seed before the vegetables are ready for harvest.
To get more of the CRISPR Medicine News delivered to your inbox, sign up to the free weekly CMN Newsletter here.